mBioMicrobiologyPeer-reviewed journal article
Neutrophil degranulation and extracellular ROS production are inactivated by Yersinia pseudotuberculosis YopE through a SKAP2 independent pathway
Pathricia A. LeusiD, Claudia M Manan Mejias, Alison Ren, Majorie de la Rosa, Emma LofgreniD, Steven C. Bunnell, D. SykesiD, Joan C. MecsasiD
Abstract
Upon sensing Yersinia pseudotuberculosis (Yptb), receptor-mediated pathways are stimulated to trigger polymorphonuclear (PMN) antimicrobial responses. Yptb injects multiple Type 3 secreted effector proteins, Yops (Yersinia outer proteins), that possess distinct biochemical functions, into PMNs to inhibit PMN responses. Here, we show that several Yops, YopE, YopH, and YopO, each partially interfered with CD63 mobilization to the plasma membrane, a marker for primary degranulation. The host pathways involved in CD63 mobilization are complex and it is not completely understood how Yops collaborate to inactivate this process. Here, CRISPR/Cas9 technology was used in an immortalized system of myeloid progenitor cells (Cas9-ER-HoxB8) to generate a panel of knockout PMN cell lines. To probe the impact of different Yops on the neutrophil pathways activated upon encountering Yptb, we interrogated the panel of genetically modified neutrophils with genetically modified bacteria. This approach of targeted gene deletion to inactivate specific pathways/proteins uncovered host pathways that synergize to induce CD63 mobilization that are distinctly targeted by YopE and YopH. YopE specifically inhibited CD63 mobilization in the absence of SKAP2, a YopH target, whereas YopH inhibited CD63 mobilization in the absence of RhoG, a YopE target, indicating that these Yops inactivate distinct signaling pathways contributing to CD63 mobilization. Furthermore, the SKAP2-independent pathway inactivated by YopE is involved in primary granule release and ROS production. Overall, this work highlights the diverse Yop-mediated mechanisms that WT-Yptb employs to effectively disarm PMN responses and provides an avenue to untangle neutrophil signaling pathways targeted by pathogens using Cas9-ER-HoxB8 cells. Author SummaryWhen sensing invading bacteria, neutrophils become activated through multiple receptors that trigger signal-transduction cascades resulting in the generation antimicrobial responses. The enteric pathogen, Yersinia pseudotuberculosis (Yptb), is equipped to effectively inhibit these responses using its collection of effector proteins (Yops). Here, we developed a system to overcome the limitations of performing genetic manipulations in neutrophils by implementing CRISPR/Cas9 technology in an engineered system of myeloid progenitor cells (Cas9-ER-HoxB8) that can be induced to differentiate into neutrophils. By infecting genetically modified neutrophils with Yptb strains expressing individual Yops, we identified distinct host signaling pathways that synergize to induce neutrophil antimicrobial responses. Our findings provide insight into several signaling events triggered by Yptb infection and show how YopE and YopH target distinct pathways to block vesicle trafficking and extracellular ROS production. This powerful genetic system can be applied to other pathogens to dissect the intricacies of neutrophil-pathogen interactions.
- organism: human
- assay: proteomics
- research focus: cell signaling & trafficking
- approach: genetic perturbation / CRISPR
- Citations
- 0
- FWCI
- 0.00
- Field percentile
- top 28%
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- Yersinia bacterium, plague, ectoparasites research
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- RIPK1 activates distinct gasdermins in macrophages and neutrophils upon pathogen blockade of innate immune signalling
K. Chen, B. Demarco, … P. Broz·bioRxiv·Jan 20, 2021
- Yersinia pestis actively inhibits the production of extracellular vesicles by human neutrophils
Katelyn R. Sheneman, Timothy D. Cummins, … Matthew B. Lawrenz·Journal of Extracellular VesiclesPeer-reviewed·Apr 1, 2025
- Immune activation of primary human macrophages is suppressed by the coordinated action of Yersinia effectors
Indra Bekere, Sören Rob, … Martin Aepfelbacher·mBioPeer-reviewed·Nov 24, 2025
- Sequentially activated death complexes regulate pyroptosis and IL-1β release in response to Yersinia blockade of immune signaling
R. S. Wertman, C. K. Go, … I. E. Brodsky·bioRxiv·Sep 14, 2023
- Inflammatory monocytes promote pyogranuloma formation to counteract Yersinia blockade of host defense
D. Sorobetea, R. Matsuda, … I. E. Brodsky·bioRxiv·Feb 6, 2022
- Yersinia Type III-Secreted Effectors Evade the Caspase-4 Inflammasome in Human Cells
J. Zhang, I. E. Brodsky, S. Shin·bioRxiv·Jan 24, 2023